الولايات المتحدة · منصات وبيانات · Finviz

Kura Oncology to Report Third Quarter Financial Results on November 10

نشره Finviz · الولايات المتحدة منذ 9 س

Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company focused on precision medicines for the treatment of cancer, today announced it will report its third quarter 2026…

اقرأ المقال كاملًا على Finviz سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (finviz.com)

يستحق القراءة أيضًا

Seeking Alpha

Renew outlines FY2027 adjusted EBITDA guidance of INR 105B to INR 109B as take-private process targets Q1 2027 close

MarketWatch

Want to help your adult kids and grandkids? Give them money while you’re still alive.

The Motley Fool

Kura Oncology to Report Third Quarter Financial Results on November 10

مشاركة

يستحق القراءة أيضًا

Renew outlines FY2027 adjusted EBITDA guidance of INR 105B to INR 109B as take-private process targets Q1 2027 close

Want to help your adult kids and grandkids? Give them money while you’re still alive.

Where Will QuantumScape Stock Be in 5 Years?

Regal Rexnord Q3 2026 slides: organic growth accelerates to 6.1%

Stock market after midterm elections: What S&P 500 history shows

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030